KEYTRUDA® (pembrolizumab) from Merck Awarded Prix Galien USA 2015 Best Biotechnology Product Award

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/24/2026

1. FDX
2. CBRS
3. HTZ
4. KBH
5. HON
6. TTWO
7. USO
8. MRK
9. QCOM
10. SPY

Go back to KEYTRUDA® (pembrolizumab) from Merck Awarded Prix Galien USA 2015 Best Biotechnology Product Award
Merck & Co. (NYSE: MRK) Delayed: 120.90 +1.30 (1.09%)
Previous Close $119.60    52 Week High $65.46 
Open $120.90    52 Week Low $47.97 
Day High $121.81    P/E 82.24 
Day Low $120.14    EPS $1.47 
Volume 1,343,772